CAS 484-14-0: Osthenol

Osthenol

Osthenol is a natural product compound, known for its osteogenic-promoting properties. It is derived from plant sources, specifically from the fruits of Cudrania tricuspidata, a member of the Moraceae family. This compound functions by modulating cellular activities associated with bone formation. Osthenol has been reported to promote the differentiation and maturation of osteoblasts, the bone-forming cells, through the activation of specific signaling pathways such as the BMP-2 and Wnt/β-catenin pathways. These pathways are crucial for enhancing the deposition of extracellular matrix and increasing the expression of osteogenic markers. The primary applications of Osthenol are in biomedical research and therapeutic developments focused on bone health. Its potential for aiding in the treatment of osteoporosis and enhancing bone regeneration makes it a subject of significant interest. Osthenol's ability to stimulate osteogenesis suggests its utility in developing novel treatments for bone-degenerative diseases and improving outcomes in regenerative medicine, particularly in tissue engineering and bone grafting procedures. Scientists continue to explore its efficacy and mechanisms in preclinical and clinical studies to better understand its full potential.

Osthenol: Natural, selective hMAO-A inhibitor with antitumor, antifungal, and antibacterial properties. Ki=0.26 μM.

Osthenol